DRKS00016698招募中未知
Modules on migraine activity - moma
Institut für soziale Padiatrie und Jugendmedizin, Ludwig-Maximilians-Universität München0 个研究点目标入组 786 人开始时间: 2021年4月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 786
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 6 Years 至 11 Years（—）
- 性别
- All
入选标准
- •Age at inclusion 6-11 years
- •- Diagnosis of migraine (ICD-10 G43.x) by a pediatrician or adolescent physician using the child-adapted ICHD-3beta criteria for migraine without aura (ICHD-3beta diagnosis 1.1), migraine with aura (ICHD-3beta diagnosis 1.2), or chronic migraine (ICHD-3beta diagnosis 1.3)
- •- History of migraine for at least 3 months
- •- History of at least 3 headache days in the last 3 months
- •- Beta-blocker, amitryptiline, topiramate (migraine prophylaxis medication) allowed if unchanged throughout study duration
排除标准
- •- Reduced intelligence (IQ<70)
- •- Severe physical or mental, acute or chronic illness other than headache
- •- Hemiplegic migraine (genetically confirmed)
- •- Fewer than 3 headache days during the 12-week (84-days) baseline period
研究者
相似试验
招募中
不适用
Project Migraine, Brain Stimulation and Full AttentioRBR-23b3ncniversidade Federal da Paraíba
已完成
不适用
The investigation of pathophysiology of migraine and mechanisms of acupuncture using Advanced-MRI. And the application for diagnosis.Migraine without auraJPRN-UMIN000028222niversity of Tsukuba, Mito medical center, Mito kyodo general hospital.40
已完成
不适用
An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult ParticipantsMigraineNCT05653986AbbVie391
撤回
3 期
Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With ErenumabMigraineNCT04114630Novartis Pharmaceuticals
终止
3 期
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic MigraineEpisodic MigraineNCT05028569AbbVie775